Status: Recruiting
Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells
The purpose of this study is to evaluate the safety and efficacy of mesenchymal stem cells (MSCs) obtained from bone marrow for the treatment of adults with active proliferative lupus nephritis. The objective of this study is to evaluate the efficacy of mesenchymal stem cells (MSCs) in achieving a full or partial response in the treatment of Lupus Nephritis (LN) during its induction period.
Participants needed: 20
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Red de Terapia CelularUpdated: Jul 24, 2025Locations: 1
Eligibility criteria
Females or males ≥18 years old who provide written informed consent at the selec... [+6]
Use of corticosteroids or mycophenolate above the doses allowed for induction, a... [+24]